Screener examples › Analyst & Estimates
Biggest analyst upside
Where Wall Street sees the most room.
“Stocks with at least 10 analysts, a Buy or Strong Buy consensus and price at least 30% below the mean price target”
Run this screen live and refine it in plain English (free, no sign-up).
US operating companies with 10+ analysts, Buy or better consensus, and price at least 30% below the mean target.
Filters: Analysts ≥ 10; Consensus Buy or better (rating ≤ 2.5); Price ≥ 30% below mean target
Top matches on data as of October 26, 2026
| Symbol | Company | Price | Mean Target | Target Upside | Analysts | Rating Score | Rating | Market Cap (USD) | Sector |
|---|---|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | $1.21 | $7.50 | 5.2% | 12 | 2 | Strong Buy | $89.3M | Healthcare |
| IMUX | Immunic, Inc. | $7.28 | $45.00 | 5.2% | 10 | 2 | Strong Buy | $309.5M | Healthcare |
| IRD | Opus Genetics, Inc. | $3.32 | $15.00 | 3.5% | 13 | 2 | Strong Buy | $317.0M | Healthcare |
| VKTX | Viking Therapeutics, Inc. | $24.21 | $98.00 | 3.0% | 15 | 2 | Strong Buy | $2.8B | Healthcare |
| CMPX | Compass Therapeutics, Inc. | $0.75 | $3.00 | 3.0% | 11 | 2 | Strong Buy | $139.6M | Healthcare |
| SLDB | Solid Biosciences Inc. | $5.81 | $22.25 | 2.8% | 11 | 2 | Strong Buy | $638.0M | Healthcare |
| WVE | Wave Life Sciences Ltd. | $3.21 | $12.25 | 2.8% | 14 | 2 | Strong Buy | $648.7M | Healthcare |
| CLYM | Climb Bio, Inc. | $8.81 | $28.60 | 2.2% | 11 | 1.83 | Strong Buy | $670.9M | Healthcare |
| QBTS | D-Wave Quantum Inc. | $11.54 | $36.60 | 2.2% | 10 | 2 | Strong Buy | $4.3B | Technology |
| OVID | Ovid Therapeutics Inc. | $2.16 | $6.25 | 1.9% | 10 | 2 | Strong Buy | $158.9M | Healthcare |
| RAPP | Rapport Therapeutics, Inc. Common Stock | $25.33 | $70.64 | 1.8% | 11 | 1.83 | Strong Buy | $1.2B | Healthcare |
| ORIC | ORIC Pharmaceuticals, Inc. | $8.96 | $24.25 | 1.7% | 11 | 2 | Strong Buy | $967.3M | Healthcare |
| NKTR | Nektar Therapeutics | $37.45 | $95.75 | 1.6% | 13 | 2 | Strong Buy | $1.2B | Healthcare |
| KURA | Kura Oncology, Inc. | $9.62 | $24.00 | 149.5% | 10 | 2 | Strong Buy | $854.8M | Healthcare |
| DYN | Dyne Therapeutics, Inc. | $15.72 | $39.00 | 148.1% | 14 | 1.8 | Strong Buy | $2.6B | Healthcare |
| NAMS | NewAmsterdam Pharma Company N.V. | $19.53 | $48.29 | 147.3% | 10 | 2 | Strong Buy | $2.4B | Healthcare |
| GLXY | Galaxy Digital | $15.68 | $38.67 | 146.6% | 10 | 2 | Strong Buy | $3.0B | Financials |
| CRWV | CoreWeave, Inc. Class A Common Stock | $55.19 | $133.27 | 141.5% | 19 | 2.11 | Buy | $30.4B | Technology |
| TNGX | Tango Therapeutics, Inc. | $22.20 | $52.67 | 137.3% | 11 | 2.25 | Buy | $3.3B | Healthcare |
| STOK | Stoke Therapeutics, Inc. | $25.46 | $58.00 | 127.8% | 10 | 2 | Strong Buy | $1.7B | Healthcare |
| JANX | Janux Therapeutics, Inc. | $16.69 | $37.67 | 125.7% | 12 | 2 | Strong Buy | $1.1B | Healthcare |
| PRAX | Praxis Precision Medicines, Inc. | $267.39 | $594.00 | 122.1% | 16 | 1.8 | Strong Buy | $7.8B | Healthcare |
| PRME | Prime Medicine, Inc. | $3.61 | $8.00 | 121.6% | 11 | 2 | Strong Buy | $639.8M | Healthcare |
| KTOS | Kratos Defense & Security Solutions, Inc. | $40.43 | $89.13 | 120.5% | 15 | 2 | Strong Buy | $7.6B | Industrials |
| RCUS | Arcus Biosciences, Inc. | $17.76 | $37.80 | 112.8% | 10 | 2 | Strong Buy | $2.2B | Healthcare |
25 matches. Research data, not investment advice.